S. 164 · 117th Congress

Advancing Education on Biosimilars Act of 2021

Introduced on Feb 2, 2021 by Margaret Wood Hassan (D-NH). One cosponsor. Became Public Law 117-8.

Stage
Became law
Public Law 117-8
Introduced
Feb 2, 2021
Cosponsors
1
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. Passed both chambers
  5. Sent to the President
  6. Became law

Official title

A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.

Subjects

  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Health personnel
  • Licensing and registrations
  • Medical education
  • Prescription drugs

Summary

By the Congressional Research Service (Public Law, Apr 23, 2021). Public domain.

Advancing Education on Biosimilars Act of 2021

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)

The FDA may also maintain and operate a website to provide educational materials about biological products.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Margaret Wood HassanD-NHSponsor

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

  1. On Motion to Suspend the Rules and Pass
    Apr 14, 2021· House· Passage· Passed 412–8

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 2, 2021Introduced in Senate
  2. Feb 2, 2021 · SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
  3. Mar 3, 2021Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S1021)
  4. Mar 3, 2021 · SenateSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)
  5. Mar 3, 2021Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S1021)
  6. Mar 3, 2021 · SenatePassed Senate without amendment by Unanimous Consent. (text: CR S1021)
  7. Mar 8, 2021 · SenateMessage on Senate action sent to the House.
  8. Mar 8, 2021 · HouseReceived in the House.
  9. Mar 8, 2021 · HouseHeld at the desk.
  10. Apr 14, 2021 · HouseMr. Pallone moved to suspend the rules and pass the bill.
  11. Apr 14, 2021 · HouseConsidered under suspension of the rules. (consideration: CR H1754-1755)
  12. Apr 14, 2021 · HouseDEBATE - The House proceeded with forty minutes of debate on S. 164.
  13. Apr 14, 2021 · HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  14. Apr 14, 2021 · HouseConsidered as unfinished business. (consideration: CR H1783-1784)
  15. Apr 14, 2021Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).(text: CR H1754)House · Roll call 101
  16. Apr 14, 2021 · HouseOn motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754)House · Roll call 101
  17. Apr 14, 2021 · HouseMotion to reconsider laid on the table Agreed to without objection.
  18. Apr 20, 2021Presented to President.
  19. Apr 20, 2021 · HousePresented to President.
  20. Apr 23, 2021Signed by President.
  21. Apr 23, 2021Signed by President.
  22. Apr 23, 2021Became Public Law No: 117-8.
  23. Apr 23, 2021Became Public Law No: 117-8.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.